Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 5345 results
Sort by: relevance publication year
Showing results for ISSN matching 2051-1426

Clinical experience with live-attenuated, double-deleted (LADD) listeria monocytogenes targeting mesothelin-expressing tumors

JOURNAL ARTICLE published November 2013 in Journal for ImmunoTherapy of Cancer

Authors: Dirk G Brockstedt | Dung T Le | Raffit Hassan | Aimee Murphy | John Grous | Thomas W Dubensky | Elizabeth M Jaffee

https://doi.org/10.1186/2051-1426-1-s1-p203 Actions

Urothelial carcinoma of donor origin in a kidney transplant patient

JOURNAL ARTICLE published December 2016 in Journal for ImmunoTherapy of Cancer

Authors: Rosa M. Michel Ortega | Daynna J. Wolff | Cynthia A. Schandl | Harry A. Drabkin

https://doi.org/10.1186/s40425-016-0167-4 Actions

CX-072 (pacmilimab), a Probody®PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study

JOURNAL ARTICLE published July 2021 in Journal for ImmunoTherapy of Cancer

Research funded by Memorial Sloan Kettering Cancer Center (P30 CA008748)

Authors: Aung Naing | Fiona Thistlethwaite | Elisabeth G.E. De Vries | Ferry A.L.M. Eskens | Nataliya Uboha | Patrick A. Ott | Patricia LoRusso | Javier Garcia-Corbacho | Valentina Boni | Johanna Bendell | Karen A. Autio | Manreet Randhawa | Greg Durm | Marta Gil-Martin | Mark Stroh | Alison L. Hannah | Hendrik-Tobias Arkenau | Alexander Spira

https://doi.org/10.1136/jitc-2021-002447 Actions

Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer

JOURNAL ARTICLE published December 2016 in Journal for ImmunoTherapy of Cancer

Research funded by National Cancer Institute (CA132714,CA047904) | Pittsburgh Foundation (M2005-0021)

Authors: Michal Radomski | Herbert J. Zeh | Howard D. Edington | James F. Pingpank | Lisa H. Butterfield | Theresa L. Whiteside | Eva Wieckowski | David L. Bartlett | Pawel Kalinski

https://doi.org/10.1186/s40425-016-0128-y Actions

868 Overall survival on tebentafusp in metastatic uveal melanoma (mUM) across the range of tumor gp100 expression levels

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Emma Leach | Sarah Stanhope | Revashnee Naidoo | Shaad Abdullah | Laura Collins | Koustubh Ranade

https://doi.org/10.1136/jitc-2021-sitc2021.868 Actions

Cross-talk between CD8+ T cells and natural killers: the role of mitochondrial Aa2+ transport

JOURNAL ARTICLE published December 2014 in Journal for ImmunoTherapy of Cancer

Authors: Roman Uzhachenko | Shawn Goodwin | Menaka Thounaojam | William Hofmeister | Anil Shanker

https://doi.org/10.1186/2051-1426-2-s3-p189 Actions

IL-2, IL-15 and IL-21 expand T cells for targeted adoptive therapy

JOURNAL ARTICLE published 2015 in Journal for ImmunoTherapy of Cancer

Authors: Zhenjiang Liu | Qingda Meng | Markus Maeurer | Elena Rangelova | Thomas Poiret | Rebecca Robertson | Aditya Ambati | Lalit Rane | Jiri Bartek | Caroline Verbeke | Oscar Persson | Matthias Löhr | Ralf Segersvärd | Ernest Dodoo

https://doi.org/10.1186/2051-1426-3-s2-p31 Actions

Correction: Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab

JOURNAL ARTICLE published October 2021 in Journal for ImmunoTherapy of Cancer

https://doi.org/10.1136/jitc-2020-001564corr1 Actions

Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?

JOURNAL ARTICLE published 2015 in Journal for ImmunoTherapy of Cancer

Authors: Wouter Hendrickx | Mariam Al-Muftah | Julie Decock

https://doi.org/10.1186/2051-1426-3-s2-p381 Actions

Profiling of coexpression of multiple immune checkpoints in the CD4+ and CD8+ T cell components of the clear cell renal cell carcinoma immune infiltrate

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Anne Monette | Nadia Al-Banna | Jean-Pierre Routy | Réjean Lapointe

https://doi.org/10.1186/2051-1426-3-s2-p272 Actions

S82. Proffered paper: In-vivo testing of PSMA-targeted T-cell immunotherapy for prostate cancer

JOURNAL ARTICLE published March 2014 in Journal for ImmunoTherapy of Cancer

Authors: Z Liu | SB Papa | J Morris | J Maher

https://doi.org/10.1186/2051-1426-2-s2-i20 Actions

Unique neoantigens expressed by melanomas and common epithelial cancers presented by multiple HLA alleles can be efficiently identified utilizing peptide prediction algorithms

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Kasia Trebska-Mcgowan | Mini Bharathan | Jared J Gartner | Todd D Prickett | Steven A Rosenberg | Paul F Robbins

https://doi.org/10.1186/2051-1426-3-s2-p57 Actions

Professional development session for early career scientists at SITC 2012

JOURNAL ARTICLE published December 2013 in Journal for ImmunoTherapy of Cancer

Authors: Christian M Capitini | William L Redmond | Kimberly A Shafer-Weaver

https://doi.org/10.1186/2051-1426-1-6 Actions

727 Resistance to enzalutamide and abiraterone drives tumor phenotypic plasticity and resistance to immune-mediated cytotoxicity

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Madeline Dahut | Kristen Fousek | Lucas Horn | Haiyan Qin | Jeffrey Schlom | Claudia Palena

https://doi.org/10.1136/jitc-2021-sitc2021.727 Actions

Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment

JOURNAL ARTICLE published December 2014 in Journal for ImmunoTherapy of Cancer

Authors: Roberta Zappasodi | Sadna Budhu | David Schaer | Xia Yang | Hong Zhong | Taha Merghoub | Jedd D Wolchok

https://doi.org/10.1186/2051-1426-2-s3-p242 Actions

Expansion and characterization of tumor-infiltrating lymphocytes from human sarcoma

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: MacLean Hall | John Mullinax | Erica Royster | Angela Reagan | Ricardo Gonzalez | Jose Pimiento | Shari Pilon-Thomas | Amod Sarnaik

https://doi.org/10.1186/2051-1426-3-s2-p19 Actions

502 Recommended phase 2 dose, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the IL-15 superagonist SO-C101 as monotherapy in patients with advanced/metastatic solid tumors

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Aurelien Marabelle | Stéphane Champiat | Vladimir Galvao | Aung Naing | Filip Janku | Patricia LoRusso | Peter Grell | Richard Sachse | David Bechard | Joachim Kiemle-Kallee | Ellena Garralda

https://doi.org/10.1136/jitc-2021-sitc2021.502 Actions

424 A phase 1b/2 randomized study of AVB-S6–500 in combination with cabozantinib versus cabozantinib alone in patients with advanced clear cell renal cell carcinoma who have received front-line treatment

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Kathryn Beckermann | Nicholas Vogelzang | Mao Shifeng | Moshe Ornstein | Neil Shah | Hans Hammers | Matthew Campbell | Xin Gao | David McDermott | Randy Anderson | Vanessa Esquibel | Eduardo Pennella | Reshma Rangwala | Eric Jonasch

https://doi.org/10.1136/jitc-2021-sitc2021.424 Actions

Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy

JOURNAL ARTICLE published December 2017 in Journal for ImmunoTherapy of Cancer

Authors: Rajeev Shrimali | Shamim Ahmad | Zuzana Berrong | Grigori Okoev | Adelaida Matevosyan | Ghazaleh Shoja E. Razavi | Robert Petit | Seema Gupta | Mikayel Mkrtichyan | Samir N. Khleif

https://doi.org/10.1186/s40425-017-0266-x Actions

iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine

JOURNAL ARTICLE published December 2014 in Journal for ImmunoTherapy of Cancer

Authors: Stéphanie Corgnac | Rachel Perret | Lianjun Zhang | Jean-Pierre Mach | Pedro Romero | Alena Donda

https://doi.org/10.1186/s40425-014-0039-8 Actions
Feedback: support@crossref.org